ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Public Policy Recs Updated for Familial Hypercholesterolemia
January 06, 2020In a special communication article, published online Jan. 2 in JAMA Cardiology, updated recommendations are presented for reducing the clinical and public health burden of familial hypercholesterolemia (FH). -
More Aggressive Tx Needed for Familial Hypercholesterolemia
September 24, 2019Even with care in specialty clinics, low-density lipoprotein cholesterol (LDL-C) persists above target levels in more than half of patients with familial hypercholesterolemia (FH) ... -
Evinacumab Gets FDA Breakthrough Therapy Designation for Homozygous Familial Hypercholesterolemia
April 07, 2017Regeneron Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation...
Pharma Sources Insight January 2025
